Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery

PHASE4TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Myocardial Injury
Interventions
DRUG

ticagrelor

ticagrelor 90 mg bid

DRUG

aspirin

aspirin 81 mg daily

Trial Locations (24)

10016

New York University School of Medicine, New York

21215

Sinai Hospital of Baltimore, Baltimore

31201

Central Georgia Heart Center, Macon

32209

University of Florida College of Medicine - Jacksonville, Jacksonville

32804

Florida Hospital Orthopaedic Institute and Fracture Care Center, Orlando

33060

University of South Florida, Tampa

36617

University of South Alabama Health System, Mobile

40536

University of Kentucky, Lexington

44106

VA Medical Center - Cleveland Louis Stokes, Cleveland

44109

MetroHealth Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

45220

Cincinnati VA Medical Center, Cincinnati

45409

Miami Valley Hospital, Dayton

46260

Saint Vincent Medical Group, Indianapolis

48043

McLaren Macomb, Mount Clemens

48202

Henry Ford Hospital, Detroit

48708

McLaren Bay Region, Bay City

55455

University of Minnesota, Minneapolis

72211

Arkansas Site Management Service, LLC, Little Rock

74104

Oklahoma Heart Institute, Tulsa

75216

VA North Texas Health Care System, Dallas

77030

University of Texas Health Science Center at Houston, Houston

97239

Oregon Health and Science University, Portland

98004

Overlake Hospital Medical Center, Bellevue

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

The Cleveland Clinic

OTHER